L. H. Schmidt

5.8k total citations · 1 hit paper
115 papers, 4.1k citations indexed

About

L. H. Schmidt is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Molecular Biology. According to data from OpenAlex, L. H. Schmidt has authored 115 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Public Health, Environmental and Occupational Health, 29 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in L. H. Schmidt's work include Malaria Research and Control (41 papers), Mosquito-borne diseases and control (12 papers) and Vector-borne infectious diseases (8 papers). L. H. Schmidt is often cited by papers focused on Malaria Research and Control (41 papers), Mosquito-borne diseases and control (12 papers) and Vector-borne infectious diseases (8 papers). L. H. Schmidt collaborates with scholars based in Germany, United States and Denmark. L. H. Schmidt's co-authors include Howard E. Skipper, Emil J. Freireich, E. A. Gehan, David P. Rall, Rainer Wiewrodt, Wolfgang E. Berdel, Hettie B. Hughes, Alessandro Marra, Richard N. Rossan and Tilmann Spieker and has published in prestigious journals such as Science, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

L. H. Schmidt

111 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

1966 1.2k citations L. H. Schmidt et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. H. Schmidt Germany	28	1.3k	1000	940	726	439	115	4.1k
M. C. Berenbaum United Kingdom	33	1.7k 1.3×	384 0.4×	748 0.8×	443 0.6×	1.5k 3.4×	100	6.1k
Hui‐Ling Chen Taiwan	38	1.9k 1.5×	438 0.4×	627 0.7×	576 0.8×	261 0.6×	167	4.6k
John J. Hutton United States	45	3.0k 2.3×	425 0.4×	545 0.6×	577 0.8×	146 0.3×	126	5.5k
G Mathé France	40	1.4k 1.1×	594 0.6×	2.2k 2.4×	336 0.5×	661 1.5×	460	6.7k
Johan Lindberg Sweden	40	1.7k 1.3×	344 0.3×	586 0.6×	1.1k 1.5×	1.1k 2.6×	163	5.1k
Paolo Arese Italy	41	1.4k 1.1×	2.2k 2.2×	401 0.4×	202 0.3×	678 1.5×	138	6.5k
Curtis R. Chong United States	26	1.9k 1.5×	289 0.3×	1.2k 1.3×	377 0.5×	650 1.5×	45	4.1k
Howard E. Skipper United States	28	1.3k 1.0×	291 0.3×	1.1k 1.2×	618 0.9×	396 0.9×	88	3.7k
John M. Kovarik Switzerland	44	1.6k 1.3×	355 0.4×	1.0k 1.1×	161 0.2×	577 1.3×	137	5.9k
Philippe Sanséau United Kingdom	23	3.0k 2.3×	241 0.2×	486 0.5×	371 0.5×	273 0.6×	46	5.5k

Countries citing papers authored by L. H. Schmidt

Since Specialization

Citations

This map shows the geographic impact of L. H. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. H. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. H. Schmidt more than expected).

Fields of papers citing papers by L. H. Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. H. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. H. Schmidt. The network helps show where L. H. Schmidt may publish in the future.

Co-authorship network of co-authors of L. H. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of L. H. Schmidt. A scholar is included among the top collaborators of L. H. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. H. Schmidt. L. H. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schulze, Arik Bernard, Michael Möhr, Jan Sackarnd, et al.. (2023). Risk Factors in HIV-1 Positive Patients on the Intensive Care Unit: A Single Center Experience from a Tertiary Care Hospital. Viruses. 15(5). 1164–1164. 1 indexed citations

Schulze, Arik Bernard, Georg Evers, Birthe Heitkötter, et al.. (2023). High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts. Translational Lung Cancer Research. 12(4). 727–741. 2 indexed citations

Spießhoefer, Jens, Carolin Henke, Hans‐Joachim Kabitz, et al.. (2020). Respiratory Muscle and Lung Function in Lung Allograft Recipients: Association with Exercise Intolerance. Respiration. 99(5). 398–408. 14 indexed citations

Schmidt, L. H., Arik Bernard Schulze, Dennis Göerlich, et al.. (2019). Blood clot removal by cryoextraction in critically ill patients with pulmonary hemorrhage. Journal of Thoracic Disease. 11(10). 4319–4327. 11 indexed citations

Mikesch, Jan‐Henrik, Wolfgang Hartmann, L. H. Schmidt, et al.. (2018). Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancer. European Respiratory Journal. 52(1). 1701637–1701637. 8 indexed citations

Schmidt, L. H., Birthe Heitkötter, Arik Bernard Schulze, et al.. (2017). Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer. PLoS ONE. 12(10). e0186280–e0186280. 53 indexed citations

Schmidt, L. H., Caroline Brand, Christoph Schliemann, et al.. (2017). CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer. Lung Cancer. 113. 121–127. 13 indexed citations

Schmidt, L. H., Caroline Brand, Christoph Schliemann, et al.. (2017). Potential therapeutic impact of CD13 expression in non-small cell lung cancer. PLoS ONE. 12(6). e0177146–e0177146. 20 indexed citations

Simon, Petra, Andrea Breitkreuz, Ulrich Luxemburger, et al.. (2015). Humoral immune responses of lung cancer patients against the Transmembrane Phosphatase with TEnsin homology (TPTE). Lung Cancer. 90(2). 334–341. 17 indexed citations

10.

Wenge, Daniela V., Linus Angenendt, Christoph Schliemann, et al.. (2015). MN1–Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells. Oncogenesis. 4(12). e179–e179. 10 indexed citations

11.

Schmidt, L. H., Christoph Schliemann, Arik Bernard Schulze, et al.. (2015). Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC. Lung Cancer. 92. 8–14. 3 indexed citations

12.

Schmidt, L. H., Andreas Kümmel, Dennis Görlich, et al.. (2015). PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. PLoS ONE. 10(8). e0136023–e0136023. 197 indexed citations

13.

Schmidt, L. H., Dennis Görlich, Tilmann Spieker, et al.. (2014). Prognostic Impact of Bcl-2 Depends on Tumor Histology and Expression of MALAT-1 lncRNA in Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(9). 1294–1304. 55 indexed citations

14.

Schmidt, L. H., Tilmann Spieker, Steffen Koschmieder, et al.. (2011). The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth. Journal of Thoracic Oncology. 6(12). 1984–1992. 464 indexed citations

15.

Schmidt, L. H., et al.. (2009). Electron transfer patterns of the di-heme protein cytochrome c4 from Pseudomonas stutzeri. Journal of Inorganic Biochemistry. 103(5). 717–722. 16 indexed citations

16.

Bittinger, Fernando, Andreas Faldum, L. H. Schmidt, et al.. (2008). TA-MUC1 epitope in non-small cell lung cancer. Lung Cancer. 63(1). 98–105. 23 indexed citations

17.

Schmidt, L. H., Hans E. M. Christensen, & Pernille Harris. (2006). Structure of plastocyanin from the cyanobacteriumAnabaena variabilis. Acta Crystallographica Section D Biological Crystallography. 62(9). 1022–1029. 14 indexed citations

18.

Schmidt, L. H., Reimer Hoffmann, & W STEENKEN. (1957). The pathogenicity of atypical chromogenic mycobacteria for the rhesus monkey.. PubMed. 75(2). 169–79. 7 indexed citations

19.

Schmidt, L. H., et al.. (1953). THE ANTIMALARIAL PROPERTIES OF 2,4-DIAMINO-5-p-CHLOROPHENYL-6-ETHYLPYRIMIDINE (DARAPRIM). Journal of Pharmacology and Experimental Therapeutics. 107(1). 61–91. 23 indexed citations

20.

Schmidt, L. H., et al.. (1951). THE INFLUENCE OF CORTISONE ON PRIMATE MALARIA. The Journal of Experimental Medicine. 94(6). 501–520. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact